Resumen de: US2025241305A1
Present invention teaches the method of using a keratin hydrolysis peptide (“KHP”) solution to prevent melon Fusarium wilt caused by the pathogenic fungus of Fusarium oxysporum f.sp melonis, FOM. By selectively choosing specific weights of feathers and water, and treating the mixture to a high-temperature high-pressure hydrolysis process, the resulting solution is confirmed to contain at least 253 peptides and then apply to the melon plants either by infusing to the soil or by leaf spraying to the melon plant at seedling stage. Optionally, the KHP solution can be diluted by water, as disclosed in the specification, for soil infusing or leaf spraying.
Resumen de: US2025241306A1
Present invention teaches the method of using a keratin hydrolysis peptide (“KHP”) solution to prevent cabbage black spot disease caused by the pathogen of Alternaria brassicicola. By selectively choosing specific weights of feathers and water, and treating the mixture to a high-temperature high-pressure hydrolysis process, the resulting solution is confirmed to contain at least 253 peptides and then apply to the cabbage plants by infusing to the soil containing the cabbage plants. Optionally, the KHP solution can be diluted by water, as disclosed in the specification before infusing to the soil.
Resumen de: US2025241307A1
The present disclosure provides aqueous solutions comprising one or more solubilized LCOs, as well as methods of deagglomerating, emulsifying and solubilizing LCOs in aqueous solutions.
Resumen de: US2025241315A1
The present invention provides yield enhancing compositions comprising Methylobacterium, methods for improving corn yield, and methods of making the compositions. Also provided are isolated yield enhancing Methylobacterium.
Resumen de: GB2637617A
Methods of infecting a mosquito with Wolbachia and controlling a mosquito population with the Wolbachia-infected mosquito are provided herein. The method includes microinjecting a suspension including Wolbachia cells and buffer into a target mosquito embryo to produce a Wolbachia-infected G0 female. The suspension including Wolbachia cells and buffer is obtained by homogenizing a donor insect embryo, tissue, and/or whole body infected with Wolbachia to form a homogenate and the Wolbachia cells are separated from the homogenate.
Resumen de: EP4591711A1
Formulations comprising one or more active agents for blood storage and transfusions are provided. Also provided methods for prolonging viability of blood and enhancing efficacy of blood transfusion.
Resumen de: MX2025003217A
The disclosure relates to genetically modified microorganisms of the genus <i>Paenibacillus</i>, for the improvement of phenotypes of plants, for example nitrogen availability for non-leguminous plants. Included are novel strains of the microorganisms, microbial consortia, and agricultural compositions comprising the same. Furthermore, the disclosure teaches methods of utilizing the described microorganisms, microbial consortia, and agricultural compositions comprising the same, in methods for imparting beneficial properties to target plant species. In particular aspects, the disclosure provides methods of increasing desirable plant traits in agronomically important species, for example nitrogen fixation, utilization, regulation, uptake, acquisition, tolerance, and/or processing in plants.
Resumen de: WO2024062134A1
The invention relates to a biofilm degrading composition comprising a DNAse, to uses thereof, and to a method of degrading biofilms comprising the application of this composition.
Resumen de: KR20250114974A
본 발명은 아시네토박터 바우마니에 대한 항균능력을 가지는 박테리오파지 vB_AbaSi_W9 및 항생제를 유효성분으로 포함하는 항균용 조성물에 관한 것으로, 상세하게는, 병원하수 샘플에서 분리한 vB_AbaSi_W9 Phage가 임상 CRAB 분리균주의 89.66%를 효과적으로 사멸하는 것을 관찰하였다. vB_AbaSi_W9 Phage은 다른 Phage들에 비해 강력하지 않은 분해 능력을 가지고 있지만, 다양한 ST형의 CRAB 임상균주에 대해 광범위한 호스트 스펙트럼을 가진다. 특히 항생제와 함께 사용될 때 더욱 큰 효과를 발휘하여 vB_AbaSi_W9 파지와 티게사이클린(Tigecycline) 및 리팜피신(Rifampicin)을 각각 조합하였을 때 높은 시너지 효과를 나타내었다.
Resumen de: MX2025000799A
Methods and compositions for use in growth of pink-pigmented facultative methylotrophs (PPFM) and/or methanotroph bacteria are provided herein, wherein the fermentation comprises hop acids to inhibit growth of bacterial contaminants.
Resumen de: WO2024248015A1
Provided is a compound having excellent controlling efficacy against noxious arthropods. A compound represented by formula (I) in formula (I), the symbols have the same meanings as those set forth in the description or an N-oxide thereof has excellent controlling efficacy against noxious arthropods.
Resumen de: WO2024243521A2
Methods for increasing a plant response to pests and/or pathogens by increasing the plant's production of one or plant defense compounds derived from anthranilate. Also provided are methods for identifying and selecting microbial strains that can be used in plant treatments to increase a plant response to attack by pests and/or pathogens.
Resumen de: JP2024069708A
To provide a novel improver of a skin resident bacteria flora.SOLUTION: There are provided: 1) a Staphylococcus aureus antibacterial agent including as an active ingredient, at least one kind of S-petasin, S-isopetasin, and fukinone; 2) a skin resident bacteria flora improver including as an active ingredient, at least one kind of S-petasin and S-isopetasin; 3) the skin resident bacteria flora improver described in the 2) which exhibits strong antibacterial activity to Staphylococcus aureus, and exhibits weak antibacterial activity to Staphylococcus epidermidis, thereby exhibiting an improvement action of the skin resident bacteria flora; 4) an anti-dandruff bacteria agent including as an active ingredient, at least one of condensed tannin and kaempferol 3-O-(6"-acetyl)-glucoside.SELECTED DRAWING: None
Resumen de: CN119486599A
The present invention relates to the field of protection of bacterial infectious disorders by compositions comprising bacterial bacteriophages. In particular to an antibacterial composition comprising: at least one bacterial bacteriophage selected from the group consisting of brachycaudal bacteriophage, muscular-tail bacteriophage and long-tail bacteriophage as an active agent in a liquid nucleus; and a gel shell encapsulating the liquid core comprising the bacterial bacteriophage and comprising colloidal particles of a dispersed ultraviolet screening agent wherein the ultraviolet screening agent is not a soluble antioxidant compound.
Nº publicación: KR20250115353A 30/07/2025
Solicitante:
앨버트아인슈타인컬리지오브메디신
Resumen de: EP4591711A1
Formulations comprising one or more active agents for blood storage and transfusions are provided. Also provided methods for prolonging viability of blood and enhancing efficacy of blood transfusion.